Why the study?
Does the combination of ginsenoside Rg3 and gemcitabine reduce tumor growth and angiogenesis in mice with Lewis lung carcinoma?
Population
40 female C57BL/6 mice (6-8 weeks old, 18-20g) implanted with Lewis lung carcinoma cells (n=40, 10 per group).
Comparison
Ginsenoside Rg3 combined with gemcitabine for 18… vs Control, gemcitabine alone, and ginsenoside Rg3…
Design
Preclinical, randomized into the following four groups, All counts were…
Follow-up
18 days
Authors
Loading...
Supports preclinical synergy in lung cancer models; leaves open translation to human trials.
Does the combination of ginsenoside Rg3 and gemcitabine reduce tumor growth and angiogenesis in mice with Lewis lung carcinoma?
The combination of ginsenoside Rg3 and gemcitabine synergistically inhibits tumor angiogenesis and growth while improving survival in a mouse model of lung cancer.
Liu et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: